Posters

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29

Sunday, September 27

3:00 PM - 4:00 PM ET

2099 - First Clinical Experience of Adaptive MRI-Guided Radiotherapy for Midline Glioma: CTV Dynamics in H3K27M-Altered Tumors
Speaker: Inokuchi, Haruo, MD, PhD - osaka metropolitan university, Osaka-city, Osaka
3:00 PM - 4:00 PM ET

2100 - <sup>177</sup>lu-Edotreotide Absorbed Dose In Patients with Gastroenteropancreatic Neuroendocrine Tumors: Dosimetry Results from Compete
Speaker: Iravani, Amir, MD - University of Washington-Fred Hutchinson Cancer Center, Seattle, WA
3:00 PM - 4:00 PM ET

2101 - Incidence and Dosimetric Correlates of Radiation-Induced Lung Injury after Adjuvant Radiotherapy for Gastric Cancer
Speaker: Isik, Hatice Kubra, MD - Marmara University Pendik Education and Research Hospital Radiation Oncology Clinic, Istanbul, Marmara
3:00 PM - 4:00 PM ET

2102 - Time to Development of Leptomeningeal Disease (LMD) among Metastatic Cancer Patients Who Undergo Stereotactic Radiosurgery (SRS)
Speaker: Jambhale, Ananya, BA - NYU Grossman School of Medicine, New York, NY
3:00 PM - 4:00 PM ET

2103 - A Nomogram Predicting Radiation-Related Lymphocyte Recovery and Its Prognostic Value for Survival in Locally Advanced Esophageal Squamous Cell Carcinoma
Speaker: Ji, Hongshan, MD - The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
3:00 PM - 4:00 PM ET

2104 - Survival Prediction after Stereotactic Radiosurgery in Patients with Brain Metastases Using a Multimodal 3D MRI-Radiomics Deep Learning Model
Speaker: Jiang, Yuming, MD - Wake Forest University School of Medicine, Winston-Salem, NC
3:00 PM - 4:00 PM ET

2105 - CT-Based Deep Learning Radiomics in Predicting Disease-Free Survival and Overall Survival for Esophageal Squamous Cell Carcinoma Undergoing Radiotherapy: A Multicenter Study
Speaker: Jin, Xiance, PhD - the 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou
3:00 PM - 4:00 PM ET

2106 - Clinical Outcomes of Brain Metastases with Infiltrative Growth Pattern Treated with Zero-Margin Radiosurgery
Speaker: Johnson, Nicholas, BS - University of Alabama at Birmingham, Birmingham, AL
3:00 PM - 4:00 PM ET

2107 - Investigation of the Subcutaneous-to-Visceral Fat Ratio as a Prognostic Biomarker for Survival after Ablative MR-Guided Adaptive Radiotherapy for Pancreatic Cancer
Speaker: Ud Din, Naseem, PhD - Miami Cancer Institute: Baptist Health South Florida, Miami, FL
3:00 PM - 4:00 PM ET

2108 - CPI-613 (Devimistat) in Combination with Chemoradiation in Patients with Pancreatic Ductal Adenocarcinoma (PDAC): Results of the Phase I Clinical Trial
Speaker: Kamgar, Mandana, MD - Medical College of Wisconsin, Milwaukee, WI
3:00 PM - 4:00 PM ET

2109 - Efficacy and Safety of Total Neoadjuvant Therapy in Elderly Patients with Locally Advanced Rectal Cancer: A Real-World Study
Speaker: Ke, Xiyang - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, 100142, China., beijing
3:00 PM - 4:00 PM ET

2110 - Primary and Complete Clinical Outcome Results from the TROG 17.03 Liver Ablative Radiotherapy with KIM (LARK) Trial
Speaker: Keall, Paul, PhD, MS, BS, FASTRO -